Anil B. Jindal
Birla Institute of Technology and Science
33 Papers
37 Citations
Anil B. Jindal is an academic researcher from Birla Institute of Technology and Science. The author has contributed to research in topics: Medicine & Chemistry. The author has an hindex of 10, co-authored 20 publications.
Chat about Author
Papers
The effect of particle shape on cellular interaction and drug delivery applications of micro- and nanoparticles.
TL;DR: The present review focuses on methods of fabrication of particles of non-spherical geometries and impact of particle shape on cellular uptake, biodistribution, tumor targeting and production of immunological responses.
171
Particle Shape: A New Design Parameter for Passive Targeting In Splenotropic Drug Delivery
TL;DR: In this paper, the role of nanoparticle shape on biodistribution of nanocarriers has been investigated for splenotropic drug delivery in the spleen, and the results suggest particle shape as an important tool for passive targeting of nanoparticles.
93
Recent advances in long-acting nanoformulations for delivery of antiretroviral drugs.
TL;DR: Current review emphasizes on the reproducibility, safety, efficacy and toxicity of LA anti-HIV nanoformulations and expatiates on application of profuse nano formulations for long-acting effect with promising preclinical discoveries and two clinical leads.
51
In situ hybrid nano drug delivery system (IHN-DDS) of antiretroviral drug for simultaneous targeting to multiple viral reservoirs: An in vivo proof of concept.
TL;DR: In situ hybrid nano drug delivery system of nevirapine (NVP) for simultaneous targeting to multiple viral reservoirs and could provide therapeutic benefits in complete eradication of HIV infections is reported.
38
Long-acting Parenteral Drug Delivery Systems for the Treatment of Chronic Diseases.
TL;DR: The use of long-acting parenteral formulations for the treatment of chronic infections such as HIV/AIDS and tuberculosis is a recent development in the field as discussed by the authors , which has the potential to improve the treatment for chronic conditions.
35